Transforming Lung Cancer Care & Early Detection in Tanzania

Bristol Myers Squibb's philanthropic arm is backing an initiative to transform lung cancer care and early detection in Tanzania, featured in an interview originally published on Devex. Dr. Nestory Masalu, head of oncology at Bugando Medical Center, describes how upfront molecular testing, precision medicine, and proactive community screening are shifting diagnoses to earlier, more treatable stages. The effort is partnering with Tanzania's Ministry of Health and the National TB and Leprosy Programme to scale the care model and build sustainable cancer-care infrastructure.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.